Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
Marksans' OTC Famotidine Tablets USP are acid reducers
Time to combine innovation, access and technology to deliver positive patient outcomes
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Subscribe To Our Newsletter & Stay Updated
